tiprankstipranks
Trending News
More News >
OmniAb (OABI)
NASDAQ:OABI
US Market

Compare OmniAb (OABI) vs. Competitors

Compare
263 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
OmniAb
$1.89
$272.08M
-3.20
-47.06%
6 Buy
0 Hold
0 Sell
Strong Buy
Cartesian Therapeutics
$8.12
$211.15M
-0.15
-52.01%
6 Buy
2 Hold
0 Sell
Strong Buy
Tiziana Life Sciences
$1.79
$175.90M
-12.95
101.09%
Atea Pharmaceuticals
$3.61
$282.04M
-2.03
8.08%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$12.78
$280.02M
-0.03
-60.80%
6 Buy
1 Hold
0 Sell
Strong Buy
Sagimet Biosciences, Inc. Class A
$5.57
$172.68M
-3.12
3.72%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OABI
OmniAb
1.89
-1.55
-45.06%
RNAC
Cartesian Therapeutics
8.12
-8.72
-51.78%
TLSA
Tiziana Life Sciences
1.48
0.64
76.19%
AVIR
Atea Pharmaceuticals
3.61
0.34
10.40%
VOR
Vor Biopharma
12.78
-18.32
-58.91%
SGMT
Sagimet Biosciences, Inc. Class A
5.57
0.39
7.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts